Inhibiting human integrin alpha4beta7

AU2026206251A1Pending Publication Date: 2026-08-06MORPHIC THERAPEUTIC INC
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
AU2026206251
Authority / Receiving Office
AU · AU
Patent Type
Applications
Current Assignee / Owner
Filing Date
2026-07-20
Publication Date
2026-08-06
Patent Text Reader

Abstract

INHIBITING HUMAN INTEGRIN α4β7 Abstract Disclosed are small molecule antagonists of human α4β7 integrin, and methods of using them to treat a number of diseases and conditions. Abstract FIG. I HTFF CPIRCH CP Company de (Ex) SMA / CAM Compounds ASCAIR FORMI I (Ca) IN - , 20 26 20 62 51 20 J ul 2 02 6 J u l 2 0 2 6 A b s t r a c t M I T U R A w i l l C h i l d s M I C R I M I S M A / C A M C o n s o m i r e s A # C A I R F r o m I F a t I N 2 0 2 6 2 0 6 2 5 1 2 0
Need to check novelty before this filing date? Find Prior Art